about-me variable
Julius Clinical invites you to their event

Public health and policy responses to NAFLD/NASH

About this event

NASH Webinar Series

Webinar 4 - Public health and policy responses to NAFLD/NASH

Topics that will be discussed:

  • The Impact of NAFLD/NASH
  • What is being done to tackle NAFLD/NASH globally and nationally
  • What still needs to be done in the fight against NAFLD/NASH
  • How can you/your country advance the battle against this “silent” condition?

Speaker: Prof Jeffrey V. Lazarus

Host: Dr. Manuel Castro Cabezas

Co-host: Prof. Christophe Moreno

Audience: Clinicians, researchers, pharmaceutical industry workers, public health workers

----------------------------------------------------------------------------------------

NASH Webinar Series

This webinar is the third webinar of the NASH webinar series, each focusing on recent developments or publications on nonalcoholic steatohepatitis (NASH). The topics and publications are selected by KOLs of NASH Clinical based on relevant ground-breaking NASH research in a high-impact journal. During these webinars we offer you the opportunity to interact with original authors and experts in the NASH field.

Julius Clinical

The Science CRO

Julius Clinical is the Contract Research Organisation (CRO) that manages global clinical drug trials that will have a major impact on medicine and make a real difference to people’s lives around the world.